Company profile

Paige.AI

Paige.AI has 1 AI-enabled medical device on the FDA list. The first decision was on September 21, 2021 and the most recent on September 21, 2021 (Paige Prostate). Its most common review panel is Pathology (1 device).

1AI devices

2021First decision

2021Latest decision

1Specialties

Timeline

September 21, 2021 · De Novo DEN200080Paige Prostate · Pathology · QPN